Notably, the secreted IL-1β/IL-18 activates downstream signaling pathways by binding to their respective receptors (IL1R1, IL-18Rα, and IL-18Rβ) on tumor cells, therapy performing multiple functions in tumor progression. The gene discussed is IL18; the disease is neoplasm.